Clinical Trial Update: Clomiphene in Males With Prolactinomas and Persistent Hypogonadism [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating clomiphene in men with prolactinomas and persistent hypogonadism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism
• Prolactinoma

Drugs mentioned

• Clomiphene (clomiphene)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Hypogonadotropic Hypogonadism, Prolactinoma | Phase 2 | Status: COMPLETED